Elanco Animal Health Incorporated Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down
Elanco Animal Health Incorporated (ELAN) reported Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down of $0 for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown · last filed 2023-05-09
- Elanco Animal Health Incorporated disposal group, not discontinued operation, loss (gain) on write-down for the quarter ending 2023-03-31 was $0.00, a 100.00% decline year-over-year.
- Elanco Animal Health Incorporated disposal group, not discontinued operation, loss (gain) on write-down for the quarter ending 2022-12-31 was -$6.00M, a 166.67% decline year-over-year.
- Elanco Animal Health Incorporated disposal group, not discontinued operation, loss (gain) on write-down for the quarter ending 2022-09-30 was -$1.00M, a 116.67% decline year-over-year.
- Elanco Animal Health Incorporated disposal group, not discontinued operation, loss (gain) on write-down for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- Elanco Animal Health Incorporated disposal group, not discontinued operation, loss (gain) on write-down for fiscal 2022 was $21.00M, a 92.61% decline from fiscal 2021.
- Elanco Animal Health Incorporated disposal group, not discontinued operation, loss (gain) on write-down for fiscal 2021 was $284.00M, a 1394.74% increase from fiscal 2020.
- Elanco Animal Health Incorporated disposal group, not discontinued operation, loss (gain) on write-down for fiscal 2020 was $19.00M, a 11.76% increase from fiscal 2019.
- Elanco Animal Health Incorporated disposal group, not discontinued operation, loss (gain) on write-down for fiscal 2019 was $17.00M.
| Period end | Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down 3 month | Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down 3 month as first filed | Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down 6 month | Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down 6 month as first filed | Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down 9 month | Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down 9 month as first filed | Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down 12 month | Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-03-31 | $0.00 10-Q · filed 2023-05-09 | -$6.00M derived: sum of 2 quarters · filed 2023-05-09 | -$7.00M derived: sum of 3 quarters · filed 2023-05-09 | -$7.00M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2022-12-31 | -$6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$7.00M derived: sum of 2 quarters · filed 2023-03-01 | -$7.00M derived: sum of 3 quarters · filed 2023-03-01 | $21.00M 10-K · filed 2023-03-01 | ||||
| 2022-09-30 | -$1.00M 10-Q · filed 2022-11-08 | -$1.00M derived: sum of 2 quarters · filed 2022-11-08 | $27.00M 10-Q · filed 2022-11-08 | $30.00M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2022-06-30 | $0.00 10-Q · filed 2022-08-08 | $28.00M 10-Q · filed 2022-08-08 | $31.00M derived: sum of 3 quarters · filed 2023-05-09 | $37.00M derived: sum of 4 quarters · filed 2023-05-09 | ||||
| 2022-03-31 | $22.00M 10-Q · filed 2023-05-09 | $28.00M 10-Q · filed 2022-05-09 | $31.00M derived: sum of 2 quarters · filed 2023-05-09 | $37.00M derived: sum of 3 quarters · filed 2023-05-09 | $304.00M derived: sum of 4 quarters · filed 2023-05-09 | |||
| 2021-12-31 | $9.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $15.00M derived: sum of 2 quarters · filed 2023-03-01 | $282.00M derived: sum of 3 quarters · filed 2023-03-01 | $284.00M 10-K · filed 2023-03-01 | $278.00M 10-K · filed 2022-02-28 | |||
| 2021-09-30 | $6.00M 10-Q · filed 2022-11-08 | $273.00M derived: sum of 2 quarters · filed 2022-11-08 | $275.00M 10-Q · filed 2022-11-08 | $291.00M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-06-30 | $267.00M 10-Q · filed 2022-08-08 | $269.00M 10-Q · filed 2022-08-08 | $285.00M derived: sum of 3 quarters · filed 2023-03-01 | $286.00M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2021-03-31 | $2.00M 10-Q · filed 2022-05-09 | $18.00M derived: sum of 2 quarters · filed 2023-03-01 | $19.00M derived: sum of 3 quarters · filed 2023-03-01 | $20.00M derived: sum of 4 quarters · filed 2023-03-01 | ||||
| 2020-12-31 | $16.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $17.00M derived: sum of 2 quarters · filed 2023-03-01 | $18.00M derived: sum of 3 quarters · filed 2023-03-01 | $19.00M 10-K · filed 2023-03-01 | $19.10M 10-K · filed 2021-03-01 | |||
| 2020-09-30 | $1.00M 10-Q · filed 2021-11-05 | $900.00K 10-Q · filed 2020-11-06 | $2.00M derived: sum of 2 quarters · filed 2021-11-05 | $3.00M 10-Q · filed 2021-11-05 | $3.20M 10-Q · filed 2020-11-06 | $9.50M derived: sum of 4 quarters · filed 2022-02-28 | ||
| 2020-06-30 | $1.00M 10-Q · filed 2021-08-09 | $2.00M 10-Q · filed 2021-08-09 | $2.30M 10-Q · filed 2020-07-30 | $8.50M derived: sum of 3 quarters · filed 2022-02-28 | $19.00M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-03-31 | $1.00M 10-Q · filed 2021-05-07 | $1.30M 10-Q · filed 2020-05-07 | $7.50M derived: sum of 2 quarters · filed 2022-02-28 | $18.00M derived: sum of 3 quarters · filed 2022-02-28 | $18.00M derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-12-31 | $6.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $17.00M derived: sum of 2 quarters · filed 2022-02-28 | $17.00M derived: sum of 3 quarters · filed 2022-02-28 | $17.00M 10-K · filed 2022-02-28 | $17.20M 10-K · filed 2020-02-28 | |||
| 2019-09-30 | $10.50M 10-Q · filed 2020-11-06 | $10.50M derived: sum of 2 quarters · filed 2020-11-06 | $10.50M 10-Q · filed 2020-11-06 | |||||
| 2019-06-30 | $0.00 10-Q · filed 2020-07-30 | $0.00 10-Q · filed 2020-07-30 | ||||||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-07 | |||||||
| 2018-12-31 | $0.00 10-K · filed 2021-03-01 | |||||||
| 2017-12-31 | $0.00 10-K · filed 2020-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |